Psychedelic research in May took another critical step forward. The publication of a large part of the phase III trial data from MAPS showed MDMA-assisted psychotherapy to be effective in the treatment of PTSD. Other research showed us the best picture of our brain under the influence of psychedelics, the genetic markers that predict the intensity of a trip, and the relationship between use of…


Previous articlePsychedelic Bulletin: MindMed CEO Steps Down; Atai Targets $2.3bn Valuation
Next articlePT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous System